Olanzapine and Drug resistance - a phase IV clinical study of FDA data
Drug resistance is found among people who take Olanzapine, especially for people who are female, 20-29 old.
The phase IV clinical study analyzes which people take Olanzapine and have Drug resistance. It is created by eHealthMe based on reports of 54,854 people who have side effects when taking Olanzapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
54,854 people reported to have side effects when taking Olanzapine.
Among them, 256 people (0.47%) have Drug resistance.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 55,438 Olanzapine users for its effectiveness, alternative drugs and more.
What is Drug resistance?
Drug resistance (reduction in effectiveness of a drug) is found to be associated with 1,111 drugs and 966 conditions by eHealthMe.
Number of Olanzapine and Drug resistance reports submitted per year:
Gender of people who have Drug resistance when taking Olanzapine*:
Age of people who have Drug resistance when taking Olanzapine *:
Common drugs people take besides Olanzapine *:
Common side effects people have besides Drug resistance *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Olanzapine and have Drug resistance?Check whether Drug resistance is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How severe was Drug resistance and when was it recovered:
Expand to all the drugs that have ingredients of olanzapine:
Alternative drugs to, pros and cons of Olanzapine:
- Olanzapine (55,438 reports)
Common Olanzapine side effects:
Browse all side effects of Olanzapine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Drug resistance treatments and more:
- Drug resistance (20,674 reports)
COVID vaccines that are related to Drug resistance:
- Drug resistance in Moderna COVID Vaccine
- Drug resistance in Pfizer BioNTech Covid Vaccine
- Drug resistance in Johnson and Johnson Covid Vaccine
Common drugs associated with Drug resistance:
All the drugs that are associated with Drug resistance:
- Drug resistance (1,111 drugs)
Common conditions associated with Drug resistance:
All the conditions that are associated with Drug resistance:
- Drug resistance (966 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine (the active ingredients of Olanzapine) and Olanzapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Erythromycin and Convulsion - 8 seconds ago
- Casodex and Iatrogenic Injury - 15 seconds ago
- Nystatin and Haemorrhoids - 21 seconds ago
- Epzicom and Pleurisy - 22 seconds ago
- Adcal and Fall - 27 seconds ago
- Fungal Oesophagitis and drugs of ingredients of levalbuterol hydrochloride - 29 seconds ago
- Combivent and Adverse Drug Reaction - 49 seconds ago
- Ezetimibe and Fatigue - a minute ago
- Prempro and Energy Increased - a minute ago
- Cannabis and Vitamin B2 drug interaction - a minute ago